http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20170689-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_021ccbeb24f269f38cd842953811b956 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004 |
| filingDate | 2015-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ed533604aafd502a154cae3db07f31a |
| publicationDate | 2017-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | PE-20170689-A1 |
| titleOfInvention | NEW IRON (III) HYDROXIDE COMPLEX WITH ACTIVATED GLUCOSE SYRUP AND PROCEDURE FOR ITS PREPARATION |
| abstract | It refers to a process for the preparation of complexes of iron (III) hydroxide and activated glucose syrup which comprises the following steps: (i) providing an aqueous solution of glucose syrup with a dextrose equivalent (DE) of at least 21 and at most 60 as determined by gravimetric analysis at a temperature in the range of 25 ° C to 80 ° C and at a pH in the range of 6 to 13; (ii) add hydrogen peroxide and optionally a catalytic amount of an oxidation catalyst to the solution (i), allowing the solution to cool to a temperature between 10 ° C to 45 ° C keeping the solution at this temperature for 5 minutes at 24 hours, obtaining the activated glucose syrup; (iii) converting said activated glucose syrup into a complex with iron (III) hydroxide; and (iv) obtaining a complex of iron (III) hydroxide and activated glucose syrup wherein the complex obtained has an iron content in the range of 27% to 35% by weight, based on the weight of the complex. It also refers to a pharmaceutical composition. This complex can be used in the therapy of iron deficiency in animals and the general population. |
| priorityDate | 2014-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.